Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nursing Management (Harrow, London, England : 1994)|January 24, 2020
Implementing a quality improvement programme in a locality mental health serviceAndrea Davies, Wendy James, Lloyd Griffiths
Leukemia & Lymphoma|April 10, 2008
Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemiaRichard E Clark, Andrea Davies, Munir Pirmohamed, et al.
Clinical Psychology & Psychotherapy|August 13, 2024
Psychological Factors Protecting Against Suicidality in Older Adults: A Systematic ReviewHannah Maynard, James D Gregory, Andrea Davies, et al.
Behavioural and Cognitive Psychotherapy|March 25, 2025
The role of suicidal mental imagery and experiential avoidance in suicidality: an exploratory studyHannah Maynard, James D Gregory, Andrea Davies, et al.
Blood|August 2, 2008
Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemiaAthina Giannoudis, Andrea Davies, Claire M Lucas, et al.
Leukemia Research|December 17, 2009
Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatographyAndrea Davies, Alison K Hayes, Katy Knight, et al.
Scientific Reports|May 23, 2020
Serotonin re-uptake transporter gene polymorphisms are associated with imatinib-induced diarrhoea in chronic myeloid leukaemia patientsAndrea Davies, Ana Eugenia Rodriguez-Vicente, Gemma Austin, et al.
Biochemical Pharmacology|January 10, 2012
Lamotrigine is a substrate for OCT1 in brain endothelial cellsDavid Dickens, Andrew Owen, Ana Alfirevic, et al.
Haematologica|August 29, 2009
Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcriptClaire M Lucas, Robert J Harris, Athina Giannoudis, et al.
Blood|December 11, 2012
The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemiaAthina Giannoudis, Lihui Wang, Andrea L Jorgensen, et al.
Pageof 2